Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - Oppenheimer
Go back to Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - Oppenheimer| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 63.94 -1.14 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.08 | 52 Week High | $108.96 | |||
| Open | $65.25 | 52 Week Low | $62.12 | |||
| Day High | $65.29 | P/E | N/A | |||
| Day Low | $63.84 | EPS | $-1.27 | |||
| Volume | 4,455,960 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 20.11 -0.56 (2.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.67 | 52 Week High | $63.73 | |||
| Open | $20.63 | 52 Week Low | $8.00 | |||
| Day High | $20.74 | P/E | N/A | |||
| Day Low | $19.62 | EPS | $-5.69 | |||
| Volume | 6,292,416 | |||||
